Dr. Michael Schwartz, professor (Metabolism, Endocrinology and Nutrition) has received a $3.1 million grant from Novo Nordisk to collaborate on exploring the role of the brain in regulating blood glucose and obesity.

The collaboration aims to understand factors mediating brain control of blood glucose and appetite with the ultimate goal of developing new therapeutic agents for the treatment of diabetes and obesity. Researchers will conduct a research program on the effect of known hormonal factors working in the brain to regulate whole body glucose metabolism and appetite.

The research will be conducted over the next three years, at UW Medicine’s South Lake Union research campus in Seattle, Washington and at Novo Nordisk’s research facilities in Måløv, Denmark.